Examples of Drug Discovery Collaboration in a sentence
Alnylam is not permitted to grant sublicenses under the licenses granted in Sections 5.1(a) through 5.1(e), except that Alnylam is permitted to grant (i) sublicenses in connection with a Bona Fide Drug Discovery Collaboration, (ii) sublicenses in connection with a Development Collaboration, (iii) Naked Sublicenses and (iv) sublicenses under the license granted in Section 5.1(e) in connection with the discovery, development or commercialization of any product.
Xxxxx Chief Financial Officer 000-000-0000 (000) 000-0000 Media Xxxxx Parrot Xxxxx Parrot & Associates 703-757-0950 DuPont and 3-Dimensional Pharmaceuticals Announce Drug Discovery Collaboration - DuPont also Licenses 3DP's DirectedDiversity(R) Drug Discovery Patents- Exton, PA and Wilmington, DE - February XX, 2000 - DuPont Pharmaceuticals Company, a wholly-owned independent subsidiary of DuPont (NYSE: DD), and 3- Dimensional Pharmaceuticals, Inc.
In the event of a Platform License, Drug Discovery Collaboration, or Development Collaboration, the percentage of the Sublicense Consideration due to MI according to Subsection (a) above shall be based on the value reasonably attributable to the Patent Rights relative to the value of such other patent rights Controlled by WAVE included in such Platform License, Drug Discovery Collaboration, or Development Collaboration (such relative value of the Patent Rights hereinafter the “Patent Rights Value”).
As these terms expire, the Board of Directors shall elect their successors who might be the same individual or a different individual.
In 2002, we entered into a Drug Discovery Collaboration Agreement with InterMune for the discovery of novel small molecule inhibitors of the Hepatitis C Virus, or HCV, NS3/4A protease.
Drug Discovery Collaboration AgreementIn July 2012, the Company entered into a drug discovery collaboration agreement with Array BioPharma Inc.
We entered into a Drug Discovery Collaboration Agreement with Genentech, a member of the Roche Group, in December 2003 to develop small molecule drugs against multiple therapeutic targets in the field of oncology.
Genentech and Array entered into a Drug Discovery Collaboration Agreement, effective as of December 22, 2003, which was subsequently modified by a Letter Agreement, dated October 11, 2004, and amended by a First Amendment, dated May 20, 2005, a Second Amendment, dated October 1, 2005 and a Third Amendment, dated April 2, 2007 (collectively, the “Agreement”).
London: Croom Helm.Drug Discovery & Development, AstraZeneca Purchases SGI Reality Center for Drug Discovery Collaboration, 2002, Drug Discovery & Development , Vol.
Genentech and Array entered into a Drug Discovery Collaboration Agreement, effective as of December 22, 2003, which was subsequently modified by a Letter Agreement, dated October 11, 2004, and amended by a First Amendment, dated May 20, 2005 (collectively, the “Agreement”).